1
|
Curvello R, Raghuwanshi VS, Wu CM, Mata J, Garnier G. Nano- and Microstructures of Collagen-Nanocellulose Hydrogels as Engineered Extracellular Matrices. ACS Appl Mater Interfaces 2024; 16:1370-1379. [PMID: 38117479 DOI: 10.1021/acsami.3c10353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/21/2023]
Abstract
The extracellular matrix (ECM) is the fundamental acellular element of human tissues, providing their mechanical structure while delivering biomechanical and biochemical signals to cells. Three-dimensional (3D) tissue models commonly use hydrogels to recreate the ECM in vitro and support the growth of cells as organoids and spheroids. Collagen-nanocellulose (COL-NC) hydrogels rely on the blending of both polymers to design matrices with tailorable physical properties. Despite the promising application of these biomaterials in 3D tissue models, the architecture and network organization of COL-NC remain unclear. Here, we investigate the structural effects of incorporating NC fibers into COL hydrogels by small-angle neutron scattering (SANS) and ultra-SANS (USANS). The critical hierarchical structure parameters of fiber dimensions, interfiber distance, and coassembled open structures of NC and COL in the absence and presence of cells were determined. We found that NC expanded and increased the homogeneity in the COL network without affecting the inherent fiber properties of both polymers. Cells cultured as spheroids in COL-NC remodeled the hydrogel network without a significant impact on its architecture. Our study reveals the polymer organization of COL-NC hydrogels and demonstrates SANS and USANS as exceptional techniques to reveal nano- and micron-scale details on polymer organization, which leads to a better understanding of the structural properties of hydrogels to engineer novel ECMs.
Collapse
Affiliation(s)
- Rodrigo Curvello
- Department of Chemical and Biological Engineering, Monash University, Clayton, Victoria 3800, Australia
| | - Vikram Singh Raghuwanshi
- Department of Chemical and Biological Engineering, Monash University, Clayton, Victoria 3800, Australia
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical and Biological Engineering, Monash University, Clayton, Victoria 3800, Australia
| | - Chun-Ming Wu
- Australian Centre for Neutron Scattering (ACNS), Australian Nuclear Science and Technology Organisation (ANSTO), Lucas Height, New South Wales 2234, Australia
- National Synchrotron Radiation Research Center, Hsinchu 300092, Taiwan
| | - Jitendra Mata
- Australian Centre for Neutron Scattering (ACNS), Australian Nuclear Science and Technology Organisation (ANSTO), Lucas Height, New South Wales 2234, Australia
- School of Chemistry, University of New South Wales, Sydney 2052, Australia
| | - Gil Garnier
- Department of Chemical and Biological Engineering, Monash University, Clayton, Victoria 3800, Australia
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical and Biological Engineering, Monash University, Clayton, Victoria 3800, Australia
| |
Collapse
|
2
|
Curvello R, Berndt N, Hauser S, Loessner D. Recreating metabolic interactions of the tumour microenvironment. Trends Endocrinol Metab 2024:S1043-2760(23)00250-3. [PMID: 38212233 DOI: 10.1016/j.tem.2023.12.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 12/05/2023] [Accepted: 12/12/2023] [Indexed: 01/13/2024]
Abstract
Tumours are heterogeneous tissues containing diverse populations of cells and an abundant extracellular matrix (ECM). This tumour microenvironment prompts cancer cells to adapt their metabolism to survive and grow. Besides epigenetic factors, the metabolism of cancer cells is shaped by crosstalk with stromal cells and extracellular components. To date, most experimental models neglect the complexity of the tumour microenvironment and its relevance in regulating the dynamics of the metabolism in cancer. We discuss emerging strategies to model cellular and extracellular aspects of cancer metabolism. We highlight cancer models based on bioengineering, animal, and mathematical approaches to recreate cell-cell and cell-matrix interactions and patient-specific metabolism. Combining these approaches will improve our understanding of cancer metabolism and support the development of metabolism-targeting therapies.
Collapse
Affiliation(s)
- Rodrigo Curvello
- Department of Chemical and Biological Engineering, Faculty of Engineering, Monash University, Melbourne, Victoria, Australia
| | - Nikolaus Berndt
- Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany; Institute of Computer-assisted Cardiovascular Medicine, Deutsches Herzzentrum der Charité, Berlin, Germany; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Sandra Hauser
- Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Department of Radiopharmaceutical and Chemical Biology, Dresden, Germany
| | - Daniela Loessner
- Department of Chemical and Biological Engineering, Faculty of Engineering, Monash University, Melbourne, Victoria, Australia; Leibniz Institute of Polymer Research Dresden e.V., Max Bergmann Center of Biomaterials, Dresden, Germany; Department of Materials Science and Engineering, Faculty of Engineering, Monash University, Melbourne, Victoria, Australia; Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, Victoria, Australia.
| |
Collapse
|
3
|
Curvello R, Kast V, Loessner D. Abstract PO-069: Modeling the tumor microenvironment using tissue engineering technologies. Cancer Res 2021. [DOI: 10.1158/1538-7445.panca21-po-069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Tissue engineering technologies provide controllable and reproducible approaches to reconstruct the extracellular and cellular elements of pancreatic cancer. In a reductionist approach they allow the modelling of the complex tumor microenvironment (TME) and the study of disease biology and anti-cancer treatments. Our objective is that an engineered TME model, that mimics the tissue and matrix composition, architecture and cell types, will behave like a real tumor and is suitable for preclinical drug testing. Using biomimetic materials, we recreated the desmoplastic tissue characteristics of the pancreatic TME. Our natural and synthetic biomaterials were tailored to achieve the mechanical properties that resembled the stiffness and viscoelasticity of patient-derived tissues, providing a supportive cell-matrix interface for 3D cell culture conditions. Pancreatic cancer cells grown embedded in the matrix scaffolds formed tumor spheroids. Cell-based assays and microscopic analysis indicated a high cell viability and proliferation of the tumor spheroids as well as the expression of cancer-associated markers. Incorporation of cancer-associated fibroblasts and myeloid cells led to a multicellular 3D systems and matrix stiffening due to the secretion of extracellular matrix proteins. Transcriptomic analysis of the 3D cell cultures identified differentially regulated pathways related to cell proliferation, mechano-transduction and the secretion of pro-inflammatory cytokines, indicative of a malignant behavior. Treatment with mechano-modulating inhibitors and anti-cancer compounds increased the efficacy of chemotherapeutics, thereby reducing matrix stiffness and the release of cytokines. Our engineered TME model provides an easily translatable technology to ease the burden of pancreatic cancer, allowing us to characterize combination treatments that slow down or reduce tumor growth.
Citation Format: Rodrigo Curvello, Verena Kast, Daniela Loessner. Modeling the tumor microenvironment using tissue engineering technologies [abstract]. In: Proceedings of the AACR Virtual Special Conference on Pancreatic Cancer; 2021 Sep 29-30. Philadelphia (PA): AACR; Cancer Res 2021;81(22 Suppl):Abstract nr PO-069.
Collapse
Affiliation(s)
| | - Verena Kast
- 2Max Bergmann Center of Biomaterials Dresden, Dresden, Germany
| | | |
Collapse
|
4
|
Curvello R, Kast V, Abuwarwar MH, Fletcher AL, Garnier G, Loessner D. 3D Collagen-Nanocellulose Matrices Model the Tumour Microenvironment of Pancreatic Cancer. Front Digit Health 2021; 3:704584. [PMID: 34713176 PMCID: PMC8521838 DOI: 10.3389/fdgth.2021.704584] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2021] [Accepted: 06/29/2021] [Indexed: 01/18/2023] Open
Abstract
Three-dimensional (3D) cancer models are invaluable tools designed to study tumour biology and new treatments. Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest types of cancer, has been progressively explored with bioengineered 3D approaches by deconstructing elements of its tumour microenvironment. Here, we investigated the suitability of collagen-nanocellulose hydrogels to mimic the extracellular matrix of PDAC and to promote the formation of tumour spheroids and multicellular 3D cultures with stromal cells. Blending of type I collagen fibrils and cellulose nanofibres formed a matrix of controllable stiffness, which resembled the lower profile of pancreatic tumour tissues. Collagen-nanocellulose hydrogels supported the growth of tumour spheroids and multicellular 3D cultures, with increased metabolic activity and matrix stiffness. To validate our 3D cancer model, we tested the individual and combined effects of the anti-cancer compound triptolide and the chemotherapeutics gemcitabine and paclitaxel, resulting in differential cell responses. Our blended 3D matrices with tuneable mechanical properties consistently maintain the growth of PDAC cells and its cellular microenvironment and allow the screening of anti-cancer treatments.
Collapse
Affiliation(s)
- Rodrigo Curvello
- Department of Chemical Engineering, Faculty of Engineering, Monash University, Clayton, VIC, Australia
| | - Verena Kast
- Max Bergmann Center of Biomaterials Dresden, Leibniz Institute of Polymer Research Dresden E.V., Dresden, Germany
| | - Mohammed H Abuwarwar
- Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia
| | - Anne L Fletcher
- Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia
| | - Gil Garnier
- Department of Chemical Engineering, Faculty of Engineering, Monash University, Clayton, VIC, Australia.,Department of Chemical Engineering, Bioresource Processing Research Institute of Australia (BioPRIA), Monash University, Clayton, VIC, Australia
| | - Daniela Loessner
- Department of Chemical Engineering, Faculty of Engineering, Monash University, Clayton, VIC, Australia.,Department of Materials Science and Engineering, Faculty of Engineering, Monash University, Clayton, VIC, Australia.,Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia
| |
Collapse
|
5
|
Mettu S, Hathi Z, Athukoralalage S, Priya A, Lam TN, Ong KL, Choudhury NR, Dutta NK, Curvello R, Garnier G, Lin CSK. Perspective on Constructing Cellulose-Hydrogel-Based Gut-Like Bioreactors for Growth and Delivery of Multiple-Strain Probiotic Bacteria. J Agric Food Chem 2021; 69:4946-4959. [PMID: 33890783 PMCID: PMC8154558 DOI: 10.1021/acs.jafc.1c00468] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/23/2021] [Revised: 03/31/2021] [Accepted: 04/14/2021] [Indexed: 05/16/2023]
Abstract
The current perspective presents an outlook on developing gut-like bioreactors with immobilized probiotic bacteria using cellulose hydrogels. The innovative concept of using hydrogels to simulate the human gut environment by generating and maintaining pH and oxygen gradients in the gut-like bioreactors is discussed. Fundamentally, this approach presents novel methods of production as well as delivery of multiple strains of probiotics using bioreactors. The relevant existing synthesis methods of cellulose hydrogels are discussed for producing porous hydrogels. Harvesting methods of multiple strains are discussed in the context of encapsulation of probiotic bacteria immobilized on cellulose hydrogels. Furthermore, we also discuss recent advances in using cellulose hydrogels for encapsulation of probiotic bacteria. This perspective also highlights the mechanism of probiotic protection by cellulose hydrogels. Such novel gut-like hydrogel bioreactors will have the potential to simulate the human gut ecosystem in the laboratory and stimulate new research on gut microbiota.
Collapse
Affiliation(s)
- Srinivas Mettu
- School
of Energy and Environment, City University
of Hong Kong, Tat Chee
Avenue, Kowloon, Hong Kong
- Chemical
and Environmental Engineering, School of Engineering, RMIT University, Melbourne, Victoria 3000, Australia
| | - Zubeen Hathi
- School
of Energy and Environment, City University
of Hong Kong, Tat Chee
Avenue, Kowloon, Hong Kong
| | - Sandya Athukoralalage
- Chemical
and Environmental Engineering, School of Engineering, RMIT University, Melbourne, Victoria 3000, Australia
| | - Anshu Priya
- School
of Energy and Environment, City University
of Hong Kong, Tat Chee
Avenue, Kowloon, Hong Kong
| | - Tsz Nok Lam
- School
of Energy and Environment, City University
of Hong Kong, Tat Chee
Avenue, Kowloon, Hong Kong
| | - Khai Lun Ong
- School
of Energy and Environment, City University
of Hong Kong, Tat Chee
Avenue, Kowloon, Hong Kong
| | - Namita Roy Choudhury
- Chemical
and Environmental Engineering, School of Engineering, RMIT University, Melbourne, Victoria 3000, Australia
| | - Naba Kumar Dutta
- Chemical
and Environmental Engineering, School of Engineering, RMIT University, Melbourne, Victoria 3000, Australia
| | - Rodrigo Curvello
- Bioresource
Processing Institute of Australia (BioPRIA), Department of Chemical
Engineering, Monash University, Clayton Victoria 3800, Australia
| | - Gil Garnier
- Bioresource
Processing Institute of Australia (BioPRIA), Department of Chemical
Engineering, Monash University, Clayton Victoria 3800, Australia
| | - Carol Sze Ki Lin
- School
of Energy and Environment, City University
of Hong Kong, Tat Chee
Avenue, Kowloon, Hong Kong
| |
Collapse
|
6
|
Curvello R, Alves D, Abud HE, Garnier G. A thermo-responsive collagen-nanocellulose hydrogel for the growth of intestinal organoids. Mater Sci Eng C Mater Biol Appl 2021; 124:112051. [PMID: 33947545 DOI: 10.1016/j.msec.2021.112051] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/11/2021] [Revised: 03/10/2021] [Accepted: 03/14/2021] [Indexed: 02/06/2023]
Abstract
Three-dimensional (3D) cell culture systems include bioengineered microenvironments that mimic the complexity of human tissues and organs in vitro. Robust biological models, like organoids and spheroids, rely on biomaterials to emulate the biochemical and biomechanical properties found in the extracellular matrix (ECM). Collagen (COL) is the main protein component of the ECM and has been used to generate fibrous matrices for 3D cell culture. Whilst neat COL gels are commonly blended with inert polymers to improve their poor mechanical properties, whether nanocellulose (NC) fibers interact or can develop some synergic bioactive effect to support organoid systems has never been demonstrated. Here, we investigate collagen-nanocellulose (COL-NC) hydrogels as a thermo-responsive matrix for the formation and growth of intestinal organoids. Cellulose nanofibres grafted with fibronectin-like adhesive sites form a porous network with type I collagen, presenting a sol-gel transition and viscoelastic profile similar to those of standard animal-based matrices. Crypts embedded in COL-NC form organoids with evidence of epithelial budding. Cell viability and metabolic activity are preserved as well as the expression of key cell markers. The stiffness of COL-NC hydrogels is shown to be a determinant element for the formation and development organoids. COL-NC hydrogels provide an affordable, performant thermo-responsive and sustainable matrix for organoid growth.
Collapse
Affiliation(s)
- Rodrigo Curvello
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical Engineering, Monash University, Australia
| | - Diana Alves
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical Engineering, Monash University, Australia
| | - Helen E Abud
- Development and Stem Cells Program, Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia
| | - Gil Garnier
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical Engineering, Monash University, Australia.
| |
Collapse
|
7
|
Curvello R, Garnier G. Cationic Cross-Linked Nanocellulose-Based Matrices for the Growth and Recovery of Intestinal Organoids. Biomacromolecules 2020; 22:701-709. [PMID: 33332099 DOI: 10.1021/acs.biomac.0c01510] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Highly carboxylated nanocellulose fibers can be functionalized with cell adhesive peptides and cationic cross-linked to form matrices for a three-dimensional (3D) cell culture. It is hypothesized that nanocellulose hydrogels cross-linked with divalent cations can provide the required biochemical and mechanical properties for intestinal organoid growth and recovery. Nanocellulose hydrogels are produced by TEMPO- and TEMPO-periodate-mediated oxidation and functionalized with RGD peptides. Mechanical properties are measured by rheology and optical properties quantified by UV-vis spectroscopy. Cellulosic matrices are cross-linked with Ca2+ and Mg2+ and intestinal organoids cultured for 4 days. The organoids are recovered for passaging and RNA extraction. TEMPO-periodate-oxidized nanocellulose fibers form functionalized hydrogels and support the growth of intestinal organoids. The highly transparent cellulosic matrix requires 4 times more Mg2+ than Ca2+ ions to reach the targeted stiffness. Organoids cultured in nanocellulose maintained a major living area for up to 4 days. Cell clusters recovered from magnesium-cross-linked hydrogels can be passaged, and their extracted RNA is intact. Cationic cross-linked nanocellulose hydrogels are promising alternative plant-based matrices for a 3D cell culture systems.
Collapse
Affiliation(s)
- Rodrigo Curvello
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical Engineering, Monash University, Melbourne, Australia
| | - Gil Garnier
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical Engineering, Monash University, Melbourne, Australia
| |
Collapse
|
8
|
Alves D, Curvello R, Henderson E, Kesarwani V, Walker JA, Leguizamon SC, McLiesh H, Raghuwanshi VS, Samadian H, Wood EM, McQuilten ZK, Graham M, Wieringa M, Korman TM, Scott TF, Banaszak Holl MM, Garnier G, Corrie SR. Rapid Gel Card Agglutination Assays for Serological Analysis Following SARS-CoV-2 Infection in Humans. ACS Sens 2020; 5:2596-2603. [PMID: 32672954 PMCID: PMC7370531 DOI: 10.1021/acssensors.0c01050] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2020] [Accepted: 07/02/2020] [Indexed: 12/24/2022]
Abstract
High-throughput and rapid serology assays to detect the antibody response specific to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in human blood samples are urgently required to improve our understanding of the effects of COVID-19 across the world. Short-term applications include rapid case identification and contact tracing to limit viral spread, while population screening to determine the extent of viral infection across communities is a longer-term need. Assays developed to address these needs should match the ASSURED criteria. We have identified agglutination tests based on the commonly employed blood typing methods as a viable option. These blood typing tests are employed in hospitals worldwide, are high-throughput, fast (10-30 min), and automated in most cases. Herein, we describe the application of agglutination assays to SARS-CoV-2 serology testing by combining column agglutination testing with peptide-antibody bioconjugates, which facilitate red cell cross-linking only in the presence of plasma containing antibodies against SARS-CoV-2. This simple, rapid, and easily scalable approach has immediate application in SARS-CoV-2 serological testing and is a useful platform for assay development beyond the COVID-19 pandemic.
Collapse
Affiliation(s)
- Diana Alves
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
| | - Rodrigo Curvello
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
| | - Edward Henderson
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
- Centre to Impact AMR,
Monash University, Clayton, Victoria
3800, Australia
| | - Vidhishri Kesarwani
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
- Centre to Impact AMR,
Monash University, Clayton, Victoria
3800, Australia
| | - Julia A. Walker
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
- Centre to Impact AMR,
Monash University, Clayton, Victoria
3800, Australia
- Monash Institute of Pharmaceutical
Sciences, Monash University, Parkville,
Victoria 3052, Australia
| | - Samuel C. Leguizamon
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
- Department of Materials Science and
Engineering, Monash University, Clayton,
Victoria 3800, Australia
- Department of Chemical Engineering,
University of Michigan, Ann Arbor,
Michigan 48109, United States
| | - Heather McLiesh
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
| | - Vikram Singh Raghuwanshi
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
| | - Hajar Samadian
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
| | - Erica M. Wood
- Department of Clinical Haematology,
Monash Health, Clayton, Victoria
3168, Australia
- Department of Epidemiology and
Preventive Medicine, Monash University,
Melbourne, Victoria 3004, Australia
| | - Zoe K. McQuilten
- Department of Clinical Haematology,
Monash Health, Clayton, Victoria
3168, Australia
- Department of Epidemiology and
Preventive Medicine, Monash University,
Melbourne, Victoria 3004, Australia
| | - Maryza Graham
- Department of Microbiology,
Monash Health, Clayton, Victoria
3168, Australia
- Monash Infectious Diseases,
Monash Health, Clayton, Victoria
3168, Australia
- Department of Clinical Sciences,
Monash University, Clayton, Victoria
3168, Australia
| | - Megan Wieringa
- Department of Microbiology,
Monash Health, Clayton, Victoria
3168, Australia
- Department of Clinical Sciences,
Monash University, Clayton, Victoria
3168, Australia
| | - Tony M. Korman
- Department of Microbiology,
Monash Health, Clayton, Victoria
3168, Australia
- Monash Infectious Diseases,
Monash Health, Clayton, Victoria
3168, Australia
- Center for Inflammatory Diseases,
Department of Medicine, Monash University,
Clayton, Victoria 3800, Australia
| | - Timothy F. Scott
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
- Department of Materials Science and
Engineering, Monash University, Clayton,
Victoria 3800, Australia
| | - Mark M. Banaszak Holl
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
| | - Gil Garnier
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
| | - Simon R. Corrie
- Department of Chemical Engineering,
ARC Centre of Excellence in Convergent BioNano Science and Technology,
Monash University, Clayton, Victoria
3800, Australia
- Bioresource Processing Research
Institute of Australia (BioPRIA), Monash
University, Clayton, Victoria 3800,
Australia
- Centre to Impact AMR,
Monash University, Clayton, Victoria
3800, Australia
- Monash Institute of Pharmaceutical
Sciences, Monash University, Parkville,
Victoria 3052, Australia
| |
Collapse
|
9
|
Curvello R, Kerr G, Micati DJ, Chan WH, Raghuwanshi VS, Rosenbluh J, Abud HE, Garnier G. Engineered Plant-Based Nanocellulose Hydrogel for Small Intestinal Organoid Growth. Adv Sci (Weinh) 2020; 8:2002135. [PMID: 33437574 PMCID: PMC7788499 DOI: 10.1002/advs.202002135] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Revised: 10/12/2020] [Indexed: 05/27/2023]
Abstract
Organoids are three-dimensional self-renewing and organizing clusters of cells that recapitulate the behavior and functionality of developed organs. Referred to as "organs in a dish," organoids are invaluable biological models for disease modeling or drug screening. Currently, organoid culture commonly relies on an expensive and undefined tumor-derived reconstituted basal membrane which hinders its application in high-throughput screening, regenerative medicine, and diagnostics. Here, we introduce a novel engineered plant-based nanocellulose hydrogel is introduced as a well-defined and low-cost matrix that supports organoid growth. Gels containing 0.1% nanocellulose fibers (99.9% water) are ionically crosslinked and present mechanical properties similar to the standard animal-based matrix. The regulation of the osmotic pressure is performed by a salt-free strategy, offering conditions for cell survival and proliferation. Cellulose nanofibers are functionalized with fibronectin-derived adhesive sites to provide the required microenvironment for small intestinal organoid growth and budding. Comparative transcriptomic profiling reveals a good correlation with transcriptome-wide gene expression pattern between organoids cultured in both materials, while differences are observed in stem cells-specific marker genes. These hydrogels are tunable and can be combined with laminin-1 and supplemented with insulin-like growth factor (IGF-1) to optimize the culture conditions. Nanocellulose hydrogel emerges as a promising matrix for the growth of organoids.
Collapse
Affiliation(s)
- Rodrigo Curvello
- Bioresource Processing Research Institute of Australia (BioPRIA)Department of Chemical EngineeringMonash UniversityClaytonVictoria3800Australia
| | - Genevieve Kerr
- Department of Anatomy and Developmental Biology and Development and Stem Cells ProgramMonash Biomedicine Discovery InstituteClaytonVictoria3800Australia
| | - Diana J. Micati
- Department of Anatomy and Developmental Biology and Development and Stem Cells ProgramMonash Biomedicine Discovery InstituteClaytonVictoria3800Australia
| | - Wing Hei Chan
- Department of Anatomy and Developmental Biology and Development and Stem Cells ProgramMonash Biomedicine Discovery InstituteClaytonVictoria3800Australia
| | - Vikram S. Raghuwanshi
- Bioresource Processing Research Institute of Australia (BioPRIA)Department of Chemical EngineeringMonash UniversityClaytonVictoria3800Australia
| | - Joseph Rosenbluh
- Department of Biochemistry and Molecular BiologyMonash UniversityClaytonVictoria3800Australia
| | - Helen E. Abud
- Department of Anatomy and Developmental Biology and Development and Stem Cells ProgramMonash Biomedicine Discovery InstituteClaytonVictoria3800Australia
| | - Gil Garnier
- Bioresource Processing Research Institute of Australia (BioPRIA)Department of Chemical EngineeringMonash UniversityClaytonVictoria3800Australia
| |
Collapse
|
10
|
Affiliation(s)
- Rodrigo Curvello
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical Engineering, Monash University, VIC 3800, Australia
| | - Llyza Mendoza
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical Engineering, Monash University, VIC 3800, Australia
| | - Heather McLiesh
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical Engineering, Monash University, VIC 3800, Australia
| | - Jim Manolios
- Haemokinesis Pty Ltd., Hallam, VIC 3803, Australia
| | - Rico F. Tabor
- School of Chemistry, Monash University, VIC 3800, Australia
| | - Gil Garnier
- Bioresource Processing Research Institute of Australia (BioPRIA), Department of Chemical Engineering, Monash University, VIC 3800, Australia
| |
Collapse
|
11
|
Oliveira LP, Perea C, Baldi C, Prata RF, Renó DL, Lima LP, Curvello R, Souza ACS. Abstract 886: Metformin effect on multidrug resistant leukemia cells: metalloproteinases 2 and 9. Cancer Res 2018. [DOI: 10.1158/1538-7445.am2018-886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Besides the progress in studies of cancer, the rates of morbidity and mortality due to this disease still considerably elevated. Chronic myeloid leukemia (CML) is a hematological neoplasm, therefore chemotherapy is the main therapeutic approach used, however most patients develop resistance to chemotherapy. Several factors contribute to this scenario, among them the lack of selective treatment, the emergence of tumor cells resistant to the wide variety of cytotoxic agents during treatment and the formation of metastases, which accounts for the majority of cancer deaths. Therefore, application of new drugs in antitumor therapies has been constantly studied. Studies have shown that metformin, an oral euglycemic used in the treatment of type II diabetes, has potential use in the treatment of cancer, potentializing the effects of standard chemotherapy used in treatment. In this work the effects of metformin on the metastatic capacity of K562 (non-resistant leukemic cell), Lucena and FEPS (leukemic cells resistant to multiple drugs) were evaluated through the study of MMP2 and MMP9 metalloproteinases, enzymes essential for the metastatic process. Thus, the present project aimed to evaluate the gene expression and enzymatic activity of MMP2 and MMP9 metalloproteinases in CML cells, before and after treatment with metformin, seeking to verify the effects of metformin on the expression and activity of these enzymes. Gene expression was evaluated using quantitative PCR and the quantification of enzymatic activity was performed by the substrate degradation using the zymography method. The results showed that metformin has the potential to modulate the expression and activity of the studied metalloproteinases.
Citation Format: Ligia P. Oliveira, Camila Perea, Caroline Baldi, Rodrigo F. Prata, Débora L. Renó, Luana P. Lima, Rodrigo Curvello, Ana Carolina S. Souza. Metformin effect on multidrug resistant leukemia cells: metalloproteinases 2 and 9 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 886.
Collapse
|
12
|
Curvello R, Neto M, Ramos S, Bin M, Shishido S, de Souza ACS. Metformin Promotes Cancer Cells Death, Inhibits PGP Expression and Sensitize MDR Leukemic Cells to the Effects of Imatinib Mesylate. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt045.5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
13
|
Neto M, Ramos S, Curvello R, Bin M, Domingues N, Rinaldi A, de Souza ACS. Exploiting Glutamine Addiction of Tumor Cells for Selective and Improved Delivery of Chemotherapic Drugs in Cancer Treatment. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt045.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
14
|
Robichon C, Annereau JP, Gomes B, Pillon A, de Vries L, Cussac D, Meyer N, Lamant L, Kruczynski A, Guilbaud N, Kluza J, Jendoubi M, Corazao-Rozas P, Andre F, Jonneaux A, Guerreschi P, Formstecher P, Mortier L, Marchetti PHI, Bozkurt E, Atmaca H, Uzunoglu S, Uslu R, Karaca B, Erenpreisa J, Jackson TR, Huna A, Salmina K, Innashkina I, Jankevics E, Townsend PA, Cragg MS, Atmaca H, Bozkurt E, Uzunoglu S, Uslu R, Karaca B, Ramos SP, Bin M, Neto MDS, Curvello R, de Souza ACS, Nunes M, Weiswald LB, Vrignaud P, Vacher S, Turlotte E, Richon S, Roman-Roman S, Bieche I, Dangles-Marie V, Morais-Santos F, Pinheiro C, Vieira A, Schmitt F, Paredes J, Baltazar F, Zhang T, Lee YW, Rui YF, Cheng TY, Li G, Sreelatha KH, Reshma RS, Veena S, Rakesh SN, Thara S, Jem P, Priya S, Veena S, Sreelatha KH, Reshma RS, Rakesh SN, Priya S. Poster session 5. Translational research. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
15
|
Koronkiewicz M, Romiszewska A, Kazimierczuk Z, Chilmonczyk Z, Neto MDS, Ramos SP, Curvello R, Bin M, Domingues NLC, Rinaldi AW, de Souza ACS, Dyshlovoy SA, Venz S, Guzii A, Makarieva T, Tabakmakher K, Stonik V, Balabanov S, Bokemeyer C, Honecker F, Flis S, Flis K, Statkiewicz M, Curvello R, Neto MDS, Ramos SP, Bin MEL, Shishido SM, de Souza ACS, Dovat S, Song C, Gowda C, Petrovic-Dovat L, Payne J, Chen LT, Tsai HJ, Kuo SH, Cheng AL, Chen J, Fu L, Kwong D, Guan X, Zalietok S, Samoylenko O, Zhuravel O, Gulua L, Orlovsky O, Chekhun V, Chekhun V, Zalietok S, Gulua L, Orlovsky O, Milinevska V, Karnaushenko O, Priya S, Reshma RS, Rakesh SN, Sreelatha KH, Veena S, Nand K, Gupta JC, Panda AK, Jain SK, Talwar GP, Riva P, Oreal P, Lima RT, Sousa D, Choosang K, Pakkong P, Palmeira A, Paiva AM, Seca H, Cerqueira F, Pedro M, Pinto MM, Sousa E, Vasconcelos MH. Poster session 3. Drug profiles - preclinical. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
16
|
Ramos S, Bin M, Neto M, Curvello R, de Souza ACS. Targeting Tumor Cell Metabolism: Restriction of Glucose Consumption Sensitizes Multidrug Resistant (MDR) Leukemia Cells to the Effects of Imatinib Mesylate. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt047.6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|